News & Views
Cambridge Enterprise Reports Successful Year
Feb 06 2013
More than £1 billion in funding has been raised by companies with roots in Cambridge research, according to year-end results from Cambridge Enterprise, the University’s commercialisation arm. The company works with University inventors and entrepreneurs to get young, high-risk companies to the stage where they can attract outside investment, through mentoring, planning advice and seed funding.
The £1 billion funding figure included in the report indicates that many go on to flourish despite the uncertain basis on which they start out. The three-year survival rate for companies is also given an as 80% compared with the national average of 58%.
One of the most successful companies in the Cambridge Enterprise portfolio is BlueGnome, which was co-founded by Dr Nick Haan, a former PhD student and post-doctoral researcher in the Department of Engineering.
The company developed technology which has been shown to increase IVF success rates by 65% over current methods. In September 2012, it was acquired by US-based life sciences company Illumina for $95 million.
The University’s proceeds from the sale will be returned to the ‘evergreen’ seed funds managed by Cambridge Enterprise, and will support the next generation of Cambridge spin-outs.
Cambridge Enterprise’s total income from licensing, consultancy and equity transactions for the year ending 31 July 2012 exceeded £9.1 million, with £7.5 million of that amount returned to the University, departments and researchers. The team completed 84 licences, signed 201 consultancy contracts and returned more than £162,000 to its seed funds.
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan